CClinicalTrials.gg
CompletedNCT05640570CCJWBTUpdated Dec 7, 2022

The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elderly With Qi-deficiency Constitution (CCJWBT): A Pragmatic Randomized Controlled Trial

A Phase 2 interventional study of The individualized Jade Wind-Barrier Herbal Tea Bag in Preventive Effectiveness, Elderly With Qi-deficiency Constitution and The Individualized Jade Wind-Barrier Herbal Tea Bag, sponsored by Hong Kong Baptist University. Completed at 1 site in China. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-07.

Sponsored by Hong Kong Baptist University · Phase 2, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Feb 2022, registered Nov 2022).
Phase
Phase 2
Study type
Interventional
Enrollment
304
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Objectives

Based on the individualized Jade Wind-Barrier Herbal Tea Bag intake after randomization, to evaluate the relationship of the individualized Jade Wind-Barrier Herbal Tea Bag intake and the improvement of Qi-deficiency Constitution on the common cold-associated outcomes.

Specific Aims 1:

To compare the incidence and recurrence of the common cold by the individualized Jade Wind-Barrier Herbal Tea Bag intake strategies (intake 3-month individualized Jade Wind-Barrier Herbal Tea Bag vs. no intake throughout the same trial period) in the HK Qi-deficiency Constitution elderly.

Specific Aims 2:

To determine the immunological index(es) and function changes by the intake strategies (intake 3-month individualized Jade Wind-Barrier Herbal Tea Bag vs. no intake throughout the same trial period) on the common cold among HK Qi-deficiency Constitution elderly.

Specific Aims 3:

To assess the change in the reductive ratio of the total scores of the Clinical Features of the Qi-deficiency Constitution Questionnaire by the individualized Jade Wind-Barrier Herbal Tea Bag intake strategies (intake 3-month individualized Jade Wind-Barrier Herbal Tea Bag vs. no intake throughout the same trial period) in the HK Qi-deficiency Constitution elderly.

02

Conditions studied

  • Preventive Effectiveness
  • Elderly With Qi-deficiency Constitution
  • The Individualized Jade Wind-Barrier Herbal Tea Bag
  • Common Cold
  • Pragmatic Randomized Controlled Trial

Browse trials for

03

In context

Common Cold

180 studies on the registry are indexed under Common Cold; 22 are open to participants now.

This study's enrollment of 304 is above the median of 167 across 151 interventional studies indexed under Common Cold.

Browse Common Cold studies →

Lead sponsor

Hong Kong Baptist University is the lead sponsor of 79 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Aged 65 years old or above,
  2. HK residents capable of consenting and have agreed to participate,
  3. Meet the assessment criteria of Qi-deficiency Constitution in TCMECQ-C at screening,
  4. The number of the incidence of the common cold ≥ 1 times/year,
  5. Able to intake the individualized Jade Wind-Barrier Herbal Tea Bag and complete the trial-related records/questionnaires and also withdraw blood.

Exclusion criteria

Exclusion Criteria:

  1. Not fulfilling the above inclusion criteria,
  2. Not assessed to be Qi-deficiency Constitution,
  3. Having serious mental and behavioral disorders that are unable to intake the individualized Jade Wind-Barrier Herbal Tea Bag, complete the trial-related records/questionnaires and withdraw blood,
  4. Having neurological disorders such as dementia etc. that are unable to intake the individualized Jade Wind-Barrier Herbal Tea Bag and complete the trial-related records/questionnaires and withdraw blood,
  5. Having serious diseases with undesirable conditions that are unable to intake the individualized Jade Wind-Barrier Herbal Tea Bag and complete the trial-related records/questionnaires and withdraw blood,
  6. Other conditions that are unable to intake the individualized Jade Wind-Barrier Herbal Tea Bag and complete the trial-related records/questionnaires and withdraw blood,
  7. Allergic to Chinese Herbal Medicine (Astragali Radix (Zhi Huangqi), Saposhnikoviae Radix (Fangfeng), Atractylodes macrocephala Koidz (Baizhu), Nelumbinis Folium (Heye), Chrysanthemum morifolium Ramat (Juhua)),
  8. Taking Chinese Herbal Medicine or drugs to manage their health problems within two weeks and cannot stop the treatment during the study,
  9. Have an abnormal liver and renal function analyzed results after randomization at screening.
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
304 participants (actual)

Study arms

  • Experimental
    The individualized Jade Wind-Barrier Herbal Tea Bag (JWBT) arm

    Drug: The individualized Jade Wind-Barrier Herbal Tea Bag

  • No intervention
    Control arm

Interventions

  • DrugThe individualized Jade Wind-Barrier Herbal Tea Bag

    The individualized Jade Wind Barrier Herbal Tea Bag is composed of Astragali Radix (Zhi Huangqi) 4g, Saposhnikoviae Radix (Fangfeng) 2g, Atractylodes macrocephala Koidz (Baizhu) 2g, Nelumbinis Folium (Heye) 1g, Chrysanthemum morifolium Ramat (Juhua) 1g.

06

What researchers measure

Primary outcomes

  1. Change in the incidence rate of the common cold from baseline (week 0) to the end of the intervention (week 13).

    Comparing Q14 incidence frequency of the common cold in the TCM Body Constitution Questionnaire (For Elderly People) (Cantonese version) (TCMECQ-C) with Q4 incidence days (convert to incidence frequency) of the common cold in the Incidence of Common Cold Record (if participants catch cold).

    Time frame: Around 30 minutes is needed to fill in both TCM Body Constitution Questionnaire (For Elderly People) (Cantonese version) (TCMECQ-C) and the Incidence of Common Cold Record (if participants catch cold).

  2. Change in the reductive ratio of the total score of CFQCQ among the HK Qi- deficiency Constitution elderly from baseline (week 0) to the end of intervention (week 13).

    Comparing the difference between the baseline score of the Clinical Features of the Qi-deficiency Constitution Questionnaire (CFQCQ) and the after intervention score of the CFQCQ.

    Time frame: Around 30 minutes is needed to fill in both the baseline and after intervention CFQCQ.

Secondary outcomes

  1. Changes in the persistence time of incident common cold among the HK Qi-deficiency Constitution elderly from baseline (week 0) to the end of intervention (week 13).

    Comparing the difference between 1st month with the 3rd month on Q4 number of incidence days of the common cold (persistence time of incident common cold) in the Incidence of Common Cold Record (if participants catch cold).

    Time frame: Around 30 minutes is needed to fill in both the baseline and after intervention Incidence of Common Cold Record (if participants catch cold).

  2. Change in intervention index of the total score of TCMSSM among the HK Qi-deficiency Constitution elderly (if catch cold) from baseline (week 0) to the end of intervention (week 13).

    Comparing the difference between the baseline and after intervention's intervention index of the total score of the Traditional Chinese Medicine Syndrome Scoring Method Questionnaire (TCMSSMQ).

    Time frame: Around 30 minutes is needed to fill in both the baseline and after intervention TCMSSM.

  3. Changes in the ranges of immune markers (Ig G, Ig A and Ig M) function analysis from baseline (week 0) to the end of intervention (week 13).

    Comparing the difference between the ranges of immune markers (IgG, IgA and IgM) function analysis from baseline (week 0) to the end of intervention (week 13).

    Time frame: Around one month respectively to complete the baseline and after trial blood withdrawal. Another one month for the corresponding ELISA test on IgG, IgA and IgM.

07

Study locations

1 site
  • School of Chinese Medicine, Hong Kong Baptist University
    Hong Kong, Hong Kong, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05640570
Lead sponsor
Hong Kong Baptist University
Collaborators
The Hong Kong Jockey Club Charities Trust
Responsible party
ZhaoXiang Bian (Chair Professor, Hong Kong Baptist University) — Principal investigator
First posted
Dec 7, 2022
Start date
Feb 21, 2022
Primary completion
Aug 8, 2022
Completion
Aug 8, 2022
Last update
Dec 7, 2022

Study contacts

Zhao-xiang Bian, PhD
principal investigator · Hong Kong Baptist University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion